Viz.ai is to enter a multi-year collaboration with Sanofi and Regeneron aimed at deploying and assessing an AI-powered ...

A district court ruled that the HHS does have the power to review drug manufacturers’ plans to pay hospitals rebates instead ...

Sanofi, a global leader in biopharmaceutical innovation, recently hosted a hybrid symposium titled "Safeguarding High-Risk Groups: The Importance of Flu Prevention and Effective Communication." The ...

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a multi-year ...

France's finance minister criticised on Thursday a decision by French drugmaker Sanofi to invest at least $20 billion in the ...

Sanofi plans to invest at least $20 billion in the United States through 2030 to boost manufacturing and research, joining ...

Sanofi plans to invest $20 billion in U.S.-based drug R&D and manufacturing over five years, creating jobs and boosting ...

The French drugmaker joined several peers in promising new investments in U.S. drug production, but cautioned plans could ...

Access to diabetes care in lower-income countries still lags for children, despite efforts from insulin makers.

Add Sanofi to the list of drugmakers committing billions to bolster their operations in the United States as President Donald ...

Roche warned that President Trump's executive order on drug pricing threatens its planned $50 billion investment in the ...

France's finance minister criticised on Thursday a decision by French drugmaker Sanofi to invest at least $20 billion in the ...